Summary by Futu AI
Novo Nordisk A/S, a global healthcare company, has filed its annual Form 11-K report with the U.S. Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report includes audited financial statements for the Novo Nordisk Inc. 401(k) Savings Plan, which is a defined contribution plan for U.S. employees. The independent auditor, EisnerAmper LLP, has expressed an unqualified opinion that the financial statements present fairly the net assets available for benefits and the changes therein for the years ended December 31, 2023, and 2022. The Plan's net assets available for benefits increased significantly from $1,769,202,694 in 2022 to $2,303,296,181 in 2023. The Plan offers a variety of investment options, including mutual funds, common stock, and common collective trusts, with the fair value...Show More